"S699 GLP-1 receptor agonists are associated with decreased esophageal " by Khaled Alsabbagh Alchirazi, Ahmed El Telbany et al.
 

S699 GLP-1 receptor agonists are associated with decreased esophageal cancer risk in type 2 diabetes patients compared to other anti-diabetic therapy

Affiliations

Aurora Healthcare, Brookfield, WI

Document Type

Abstract


 

Share

COinS